Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2024

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended
	March 31,
	2024		2023
	(in thousands)
Insurance carriers	$	341,028	$	210,378
Laboratory and other partners		20,276		22,805
Patients		6,437		8,573
Total revenues	$	367,741	$	241,756

Schedule of total revenue by geographic area

	Three months ended
	March 31,
	2024		2023
	(in thousands)
United States	$	359,413	$	233,254
Americas, excluding U.S.		1,481		1,158
Europe, Middle East, India, Africa		5,178		5,196
Asia Pacific and Other		1,669		2,148
Total revenues	$	367,741	$	241,756

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at
	March 31,		December 31,
	2024		2023
	(in thousands)
Assets:
Accounts receivable, net	$	288,748	$	278,289
Liabilities:
Deferred revenue, current portion	$	17,705	$	16,612
Deferred revenue, long-term portion		18,828		19,128
Total deferred revenues	$	36,533	$	35,740

Schedule of changes in the balance of deferred revenues

	March 31,
	2024			2023
	(in thousands)
Beginning balance	$	35,740	$	30,778
Increase in deferred revenues		7,941		12,100
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(7,048)		(3,988)
Revenue recognized from performance obligations satisfied within the same period		(100)		(800)
Ending balance	$	36,533	$	38,090